Speaker Profile
Ph.D., Chief Technical Officer, DELFI Diagnostics
Biography
Amoolya Singh is Chief Technology Officer at DELFI Diagnostics. Previously, she was Senior Vice President of Research and Chief Scientific Officer at GRAIL, and prior to that, she was Head of Discovery at Calico Life Sciences, where she catalyzed multiple productive collaborations between computational groups and experimental groups. Amoolya earned a PhD in computational biology and a MS in computer science at the University of California at Berkeley. She holds a BS degree in biology and computer science from Carnegie Mellon. Amoolya completed a postdoctoral fellowship at the European Molecular Biology Lab in Heidelberg, Germany in 2008 and a Computational and Life Sciences fellowship at Emory University in 2011 in comparative genomics and metagenomics, population genetics and experimental evolution.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Victor Velculescu, Johns Hopkins
PMWC Award Ceremony
• Pioneer Honoree: Klaus Pantel, UKE & ELBS
• Luminary: Rebecca Fitzgerald, University of Cambridge
Keynote
• Klaus Pantel, UKE & ELBS
Advancing Minimal Residual Disease (MRD) Detection through cfDNA and cfRNA Profiling
• Chair: Luis Diaz, MSKCC
• Anne-Renee Hartman, Adela
Early Cancer Detection / Regulatory / Population Health
• Peter Bach, DELFI Diagnostics
• Joshua J. Ofman, GRAIL
Role of AI in Liquid Biopsies and Cancer Detection
• Chair: Amoolya Singh, DELFI Diagnostics
